Influenza | CHOP Research Institute


Improving the health of children and enhancing primary care practice by conducting and fostering national collaborative practice-based research.​

The Eisenlohr Lab studies fundamental aspects of host defense, primary against virus infections such as influenza and HIV.

Published on
Mar 5, 2021
This week’s In the News features tetralogy of Fallot, CPR, stroke after SARS-CoV-2 infection, and a link between oxygen therapy and influenza.

The two areas of investigation in the Sengupta Lab are determining the mechanisms of the circadian regulation of lung inflammation, injury and repair/regeneration; and effect of early life exposures on the development (or maldevelopment) and function of pulmonary circadian networks in adulthood.

Dr. Sengupta is a neonatologist and physician scientist with a long-standing interest in lung health. She studies the mechanisms of circadian regulation of lung inflammation, injury, and repair; and the effect of early life exposures on development and function of pulmonary circadian networks in adulthood.

senguptas [at]
Published on
Feb 6, 2018
In the midst of flu season, our researchers are learning about what might influence a child's immune response, such as past exposure, age, and severity.
Published on
Feb 14, 2017
Let's say you want to buy a new television. You probably would do some digging and compare each brand's best features and consult reviews from other consumers before making a purchase. The decision-making process isn't always as straightforward, however, when you're faced with making a choice about your healthcare. Compelling information about the benefits and harms of a medical test,
Published on
Feb 6, 2015
While influenza vaccination is important for all children, it is critical that pediatric patients with cancer get a flu shot because their weakened immune systems leave them especially vulnerable to severe infections.
Published on
Feb 19, 2014
The Children’s Hospital of Philadelphia Research Institute’s chief scientific officer, Philip R. Johnson, MD, is among the co-authors of a new study that presents an advanced approach to vaccine design.